Abakavir/lamivudin Pliva 600 mg/300 mg filmom obložene tablete
Name | Abakavir/lamivudin Pliva 600 mg/300 mg filmom obložene tablete |
---|---|
Marketing Authorisation Number | HR-H-263764683 |
Active Substance | abakavir lamivudin |
Composition | svaka filmom obložena tableta sadrži 600 mg abakavira i 300 mg lamivudina |
Pharmaceutical Form | filmom obložena tableta |
Manufacturer | Pliva Hrvatska d.o.o., Zagreb, Hrvatska Merckle GmbH, Ulm, Njemačka |
Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
Marketing Authorisation Date | 10.07.2020 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/20-02/43 |
Registration Number | 381-12-01/154-20-03 |
Prescription | Medicinal product subject to medical prescription |
Type of prescription | ograničeni recept |
Distribution | Supply through pharmacies (community) |
Advertising to general public | not allowed |
ATC Code | J05AR02 |
Marketing status | stavljeno u promet |
Shortage status | nema nestašice |
SmPC | download |
PL | download |
Public Assessment Report | download |